BIO-RAD LABORATORIES-A (BIO) Stock Cash Flow
NYSE:BIO - New York Stock Exchange, Inc. - US0905722072 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 96.00M | 106.00M | 108.00M | 85.80M | 47.80M | |||
| Interest Paid | -47.00M | -47.00M | -47.00M | -24.40M | -2.30M | |||
| Taxes Paid | -103.06M | -99.00M | -130.00M | -158.30M | -134.70M | |||
| OPERATING CASH FLOW | 515.00M | 455.00M | 375.00M | 194.40M | 669.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -183.00M | -189.00M | -157.00M | -112.80M | -133.70M | |||
| Other Investing Activity | 68.92M | 29.00M | 177.00M | -1.09B | -663.60M | |||
| INVESTING CASH FLOW | -114.10M | -160.00M | 20.00M | -1.21B | -797.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -380.00K | -400.00K | -470.00K | 1.19B | -3.00M | |||
| Stock Issued/Repurchased | -282.76M | -184.00M | -410.00M | -198.10M | -29.40M | |||
| Other Financing Activity | -33.38M | -34.00M | -15.00M | -14.00M | -23.00M | |||
| FINANCING CASH FLOW | -317.02M | -219.00M | -426.00M | 973.60M | -55.40M | |||
| Exchange Rate Effect | 4.74M | 9.20M | 320.00K | 3.00M | -12.60M | |||
| CHANGE IN CASH | 88.62M | 85.20M | -30.68M | -36.60M | -195.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 515.00M | 455.00M | 375.00M | 194.40M | 669.50M | |||
| Capital Expenditure | -183.00M | -189.00M | -157.00M | -112.80M | -133.70M | |||
| FREE CASH FLOW | 332.00M | 266.00M | 218.00M | 81.60M | 535.80M | |||
All data in USD